It is still unclear whether improvements in prophylaxis and medical care have reduced the time patients spend in hospital after AIDS diagnosis. Several reports indicate that the average duration of hospitalization of AIDS patients has decreased since the beginning of the AIDS epidemic 2-4, but insufficient attention has been given to the possibility of cross-sectional bias. This was suggested to us when analyzing the results for the Geneva component of the Swiss HIV cohort study. In a first crosssectional analysis, we found and reported a linear decline in cumulative length of hospitalization of AIDS patients between 1981 and 19905. However, a subsequent analysis stratified into cohorts according to year of AIDS diagnosis did not confirm the decline. In addition, it suggested that the timing of hospitalization varied according from cohort to cohort. More recently diagnosed AIDS patients were hospitalized for shorter periods early after diagnosis, but for longer periods later on.
In the present paper we describe the duration of hospital stays during the two years after diagnosis. We studied the hospital days used by AIDS patients rather than exploring the hospitalisation histories of individual patients because we were interested in estimating the resources provided by the institution. We stratified patients on the basis of AIDS diagnosis before or after 1988, because this was the year of the introduction of zidovudine and Pneurnocystis carinii (PCP) prophylaxis. We also stratified on duration of follow-up, to adjust for the survival bias involved in assessing hospital stays. All patients were followed for at least 6 months after the AIDS diagnosis to allow the identification of patterns of repeated hospitalizations.
Methods

Population
All patients were eligible for the present study who 1) met the 1987 CDC criteria for AIDS 6, 2) were hospitalized before December 31, 1990, for more than one day at the University Hospital of Geneva (the Canton of Geneva has one of the highest incidence rates of Soz.-Pr~ventivmed. 1997; 42:314-319 AIDS in EuropeT-8). The sample of 212 patients represented 83 % of all AIDS cases diagnosed during that period in the Canton of Geneva according to the data of the Geneva Department of Public Health 8. Sociodemographic variables (sex, age, risk factors), and date of AIDS diagnosis and every admission to discharge from hospital, were abstracted from medical charts and from the Swiss HIV cohort study (SHCS) database using standardized forms. The SHCS has been described in detail elsewhere 9. Briefly, the cohort comprises all HIV positive patients followed in University Hospitals in Switzerland. In the SCHS, the major risk factor for AIDS and the date of initial diagnosis of AIDS are determined for all subjects by their physicians. The level of CD4+ T lymphocytes was determined as close as possible to the time of diagnosis by standardized methods 10.
Statistical analysis
The statistical analysis was restricted to subjects followed for 6 months to 2 years from the day of AIDS diagnosis, to the last information date available or death. We report the categorical data in a percentage and frequency table, and continuous data as means (+_ standard deviation). We calculated the average of duration of hospital stays per semester after the AIDS diagnosis, stratified on diagnosis before and after 1988. The average duration of hospital stays was the mean of cumulated days spent in hospital during a given period of time, divided by the number of hospital admissions. The comparisons of categorical data were done using the chi-squared test, and the comparisons of continuous date were assessed by the Mann-Whitney Utest or the t-test on logarithmic transformations.
Results
In the whole sample (n = 212), the mean age was 34.9 years (_+ 9.2 years), 81% were male, 43 % were homosexual or bisexual (HS/BS), and 35% were intravenous drug users (IVDU). Table i shows that there were no significant differences in sex, age, and risk factors whether AIDS was diagnosed before (n=71) or since 1988 (n = 141). Neither were there significant differences in frequency of opportunistic infections. Thirty five percent of patients who had AIDS before 1988 received zidovudine, and 71% of those diagnosed since 1988 (p=0.001). Patients diagnosed since 1988 had lower CD4 counts at the time of AIDS diagnosis (median = 60/mm 3) than patients diagnosed before 1988 (median 120/mm 3, p <0.0001) (not shown in a table). Table 2 shows the number of hospitalizations and their durations by semester after AIDS diagnosis, stratified on the time of diagnosis. In each case the analysis was done within a period of time for which the patients were known to be alive. The results are globally similar, but for the patients with a followup lasting > 18 months, the pattern of hospitalization durations differed strongly by semester according to the period of AIDS diagnosis ( Figure 1, Figure 2 ). For the patients diagnosed before 1988, shorter hospital stays occurred at the median period of follow-up. Lengths of hospital stays seem to be less variable for the recent patients. Mean age (mean • SD) 34.9 + 9.7 34.7 _+ 9.9 34.9 +_ 9.7 Gender (n, %) Semesters after AIDS
Figure 2. Average hospital days per semester for AIDS patients stratified on the year of diagnosis for patients followed > 24 months.
course of HIV infection, as is shown by their lower CD4 counts at the time of AIDS diagnosis. Thus, preventive measures, such as pentamidine inhalations 11-13 and zidovudine administration 14,1s now postpone the diagnosis of AIDS until immunosnppression is more advanced. After diagnosis, the mean number of hospital days is table for recent patients but a different pattern emerged for the patients diagnosed earlier. The pattern suggests that patients diagnosed before 1988 spent longer in hospital soon after diagnosis, because diagnostic and therapeutic procedures were less codified than they are today. As immunosuppression progresses, diseases such as disseminated mycobacterial infections, cachexia and diarrhea, AIDS-related dementia, and lymphoma, are less easily managed outside the hospital, so that more hospitalization is required during the second year after diagnosis. This effect was more pronounced for the patients in the earlier group, for whom prophylaxis regimens, especially against Pneurnocystis carinii pneumonia, encephalitis toxoplasmosis and mycobacterial infections, were less used. A limitation of the present study was the lack of information on hospital service consumption by HIV positive patients prior to the diagnosis of AIDS. The changes in the pattern of hospitalization during the first two years of AIDS diagnosis that we observed may be related to complementary changes during the pre-AIDS period. A study 4 found that the number of hospital days spent by HIV positive patients without AIDS doubled between 1986 and 1990. Future studies should also analyse the pre-AIDS period to clarify fully the impact on medical services on time spent in hospital by patients infected by HIV before AIDS in the era of HIV protease inhibitors. Another limitation was that the analysis was carried out only for patients with a follow-up period > 6 months. This excluded the patients with severe disease who died soon after the AIDS diagnosis. 
